Clinical Assistant Professor of Medicine, University of Pittsburgh
Dr. McCreary’s primary research interests focus on a “bench to bedside” approach of optimizing pharmacokinetic and pharmacodynamic principles for antimicrobial utilization and translational antibiotic stewardship initiatives. In less than 18 months at UPMC, she led and implemented stewardship initiatives including: dose-optimization of anti-pseudomonal beta-lactam antibiotics, comprehensive antimicrobial dosing chart by indication, transplant prophylaxis guideline updates, novel necrotizing skin and soft tissue infection pathway, evaluation and assessment of beta-lactam allergy pathway, vancomycin area-under-the-curve-based dosing pharmacokinetic service, and antifungal stewardship.
Dr. McCreary is a pharmacist who serves as the Chair of the UPMC System COVID-19 Therapeutics Committee. She also engages in tele-stewardship with several communities hospitals and rounds with the Presbyterian Shadyside infectious diseases consult services. She specializes in the management of patients infected by drug-resistant and/or fungal pathogens.
One way to speed up clinical trials: Skip right to the data with electronic medical records
Apr 06, 2023 07:53 am UTC| Insights & Views
Scientific knowledge, as measured by numbers of papers published, has been estimated to double every 17.3 years. However, it takes an average of about 17 years for health and medical research going from basic lab studies...
Electricity from farm waste: how biogas could help Malawians with no power
What the Supreme Court is doing right in considering Trump’s immunity case
US student Gaza protests: five things that have been missed
Will Solomon Islands’ new leader stay close to China?
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects